solifenacin succinate has been researched along with fentanyl in 1 studies
Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (fentanyl) | Trials (fentanyl) | Recent Studies (post-2010) (fentanyl) |
---|---|---|---|---|---|
522 | 194 | 343 | 15,288 | 4,310 | 4,483 |
Protein | Taxonomy | solifenacin succinate (IC50) | fentanyl (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.5 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.6342 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0122 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.1888 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0122 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.0058 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.3092 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 5.893 | |
Kappa-type opioid receptor | Homo sapiens (human) | 1.58 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0031 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.8197 | |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 4.973 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.354 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agrawal, S; Kanaskar, J; Kumar, S; Nigam, R; Rambhad, S; Srivastava, VK | 1 |
1 trial(s) available for solifenacin succinate and fentanyl
Article | Year |
---|---|
Evaluation of the efficacy of solifenacin and darifenacin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
Topics: Analgesics, Opioid; Benzofurans; Double-Blind Method; Female; Fentanyl; Humans; Intraoperative Period; Male; Pain, Postoperative; Prospective Studies; Pyrrolidines; Solifenacin Succinate; Treatment Outcome; Urinary Bladder; Urinary Catheterization; Urological Agents | 2016 |